General Information
Revision date
2020-03-23
Product name
MEDROXYPROGESTERONE 17-ACETATE
CAS No.
71-58-9
1.2.1 Relevant identified uses
For laboratory research purposes Not for drug or household use
Manufacturer Name
BioVision, Inc
Emergency telephone
OTHER CALLS
Icons in SDS
Company Information
company name
BioVision, Inc
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H351
Hazard statements
Code
Statements
H351
Suspected of causing cancer
Section 2
SECTION 2: Hazards identification
NFPA Rating Component Description Volume Safety Information MEDROXYPROGESTERONE 17-ACETATE Solid B2192-100: 100 mg See below B2192-500: 500 mg MEDROXYPROGESTERONE 17-ACETATE: Emergency Overview
2.1 Classification of the substance or mixture
Acute toxicity, Oral (Category 4) Skin Corrosion/Irritation (Category 2) Serious eye damage (Category 2) Toxic to Reproduction (Category 2) Target organ systemic toxicity (Category 3)
Signal word
Warning
Hazard statements
H351 Suspected of causing cancer.
Precautionary statements
P280 Wear protective gloves/protective clothing/eye protection/face protection P308+313 If exposed or concerned: Get medical advice/attention
Health hazards
2 Flammability: 0 2 Fire: 0 Reactivity Hazard: 0
Physical hazards
0
